Publications
Search our publications below…
Reforming disease definitions: a new primary care led, people-centred approach
Moynihan, R., Brodersen, J., Heath, I., Johansson, M., Kuehlein, T., Minué-Lorenzo, S., Petursson, H., Pizzanelli, M., Reventlow, S., Sigurdsson, J., Stavdal, A., Treadwell, J., & Glasziou, P.
Availability and readability of patient education materials for deprescribing: An environmental scan
Fajardo, M. A., Weir, K. R., Bonner, C., Gnjidic, D., & Jansen, J.
An Australian community jury to consider case-finding for dementia: Differences between informed community preferences and general practice guidelines
Thomas, R., Sims, R., Beller, E., Scott, A. M., Doust, J., Le Couteur, D., Pond, D., Loy, C., Forlini, C., & Glasziou, P.
Australia is responding to the complex challenge of overdiagnosis
Moynihan, R., Barratt, A. L., & Glasziou, P. P.
Care for low back pain: can health systems deliver?
Traeger, A. C., Buchbinder, R., Elshaug, A. G., Croft, P. R., & Maher, C. G.
Exploring variation in low-value care: a multilevel modelling study
Badgery-Parker, T., Feng, Y., Pearson, S. A., Levesque, J. F., Dunn, S., & Elshaug, A. G.
Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis
McCaffery, K., Nickel, B., Pickles, K., Moynihan, R., Kramer, B., Barratt, A., & Hersch, J.
Measuring Hospital-Acquired Complications Associated With Low-Value Care
Badgery-Parker, T., Pearson, S. A., Dunn, S., & Elshaug, A. G.
Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach
Pathirana, T., Hayen, A., Doust, J., Glasziou, P., & Bell, K.
Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?
Bell, K. J. L., Doust, J., Glasziou, P., Cullen, L., Harris, I. A., Smith, L., Buchbinder, R., & Barratt, A.
Subacromial decompression surgery for adults with shoulder pain: a clinical practice guideline
Vandvik, P. O., Lähdeoja, T., Ardern, C., Buchbinder, R., Moro, J., Brox, J. I., Burgers, J., Hao, Q., Karjalainen, T., van den Bekerom, M., Noorduyn, J., Lytvyn, L., Siemieniuk, R. A. C., Albin, A., Shunjie, S. C., Fisch, F., Proulx, L., Guyatt, G., Agoritsas, T., & Poolman, R. W
Public perceptions of changing the terminology for low-risk thyroid cancer: a qualitative focus group study
Nickel, B., Semsarian, C., Moynihan, R., Barratt, A., Jordan, S., McLeod, D., Brito, J. P., & McCaffery, K.
Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
Moynihan, R., Lai, A., Jarvis, H., Duggan, G., Goodrick, S., Beller, E., & Bero, L.
Citizens’ juries can bring public voices on overdiagnosis into policy making
Degeling, C., Thomas, R., & Rychetnik, L.
The impact of legislation mandating breast density notification – Review of the evidence
Houssami, N., & Lee, C. I.
Improving health literacy through adult basic education in Australia
Morony, S., Lamph, E., Muscat, D., Nutbeam, D., Dhillon, H. M., Shepherd, H., Smith, S., Khan, A., Osborne, J., Meshreky, W., Luxford, K., Hayen, A., & McCaffery, K. J.
Association of preferences for papillary thyroid cancer treatment with disease terminology: a discrete choice experiment
Nickel, B., Howard, K., Brito, J. P., Barratt, A., Moynihan, R., & McCaffery, K.